$NBRV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nabriva Therapeutics plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Nabriva Therapeutics plc. Get notifications about new insider transactions in Nabriva Therapeutics plc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 01 2019 | NBRV | Nabriva Therapeuti ... | Bourdow Carrie L. | Director | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Aug 01 2019 | NBRV | Nabriva Therapeuti ... | Broom Colin MD | Director | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Aug 01 2019 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Jul 25 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Grant | A | 0.00 | 6,748 | 0 | 67,489 | 60.7 K to 67.5 K (+11.11 %) |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | President & COO | Option Exercise | A | 0.00 | 105,750 | 0 | 105,750 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | President & COO | Option Exercise | A | 0.00 | 278,400 | 0 | 278,400 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 52,500 | 0 | 52,500 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 138,200 | 0 | 138,200 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Lavino Francesco Maria | Chief Commercial Of ... | Option Exercise | A | 0.00 | 52,500 | 0 | 52,500 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Lavino Francesco Maria | Chief Commercial Of ... | Option Exercise | A | 0.00 | 138,200 | 0 | 138,200 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Crotty Robert | Gen Counsel & Corp ... | Option Exercise | A | 0.00 | 52,500 | 0 | 52,500 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Crotty Robert | Gen Counsel & Corp ... | Option Exercise | A | 0.00 | 138,200 | 0 | 138,200 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Schranz Jennifer | Chief Medical Offic ... | Option Exercise | A | 0.00 | 52,500 | 0 | 52,500 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Schranz Jennifer | Chief Medical Offic ... | Option Exercise | A | 0.00 | 235,000 | 0 | 235,000 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 163,250 | 0 | 163,250 | |
| Feb 04 2019 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 429,800 | 0 | 429,800 | |
| Dec 27 2018 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Buy | P | 1.31 | 53,000 | 69,430 | 53,000 | 0 to 53 K |
| Aug 03 2018 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | President and COO | Option Exercise | A | 0.00 | 32,000 | 0 | 32,000 | |
| Aug 03 2018 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | President and COO | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Aug 02 2018 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Aug 02 2018 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Buy | P | 2.75 | 14,500 | 39,875 | 47,640 | 33.1 K to 47.6 K (+43.75 %) |
| Aug 02 2018 | NBRV | Nabriva Therapeuti ... | BURGESS DANIEL D | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Aug 02 2018 | NBRV | Nabriva Therapeuti ... | BURGESS DANIEL D | Director | Buy | P | 2.75 | 36,000 | 99,000 | 36,000 | 0 to 36 K |
| Jul 27 2018 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | President and COO | Option Exercise | A | 0.00 | 77,500 | 0 | 77,500 | |
| Jul 27 2018 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Jul 27 2018 | NBRV | Nabriva Therapeuti ... | Schroeder Theodore R | Chief Executive Off ... | Option Exercise | A | 0.00 | 850,000 | 0 | 850,000 | |
| Jun 26 2018 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | Chief Scientific Of ... | Buy | P | 3.82 | 10,000 | 38,200 | 22,740 | 12.7 K to 22.7 K (+78.49 %) |
| Jun 25 2018 | NBRV | Nabriva Therapeuti ... | Schranz Jennifer | Chief Medical Offic ... | Buy | P | 3.73 | 5,500 | 20,515 | 5,500 | 0 to 5.5 K |
| Jun 25 2018 | NBRV | Nabriva Therapeuti ... | Schranz Jennifer | Chief Medical Offic ... | Buy | P | 3.73 | 5,500 | 20,515 | 5,500 | 0 to 5.5 K |
| Jun 25 2018 | NBRV | Nabriva Therapeuti ... | Broom Colin MD | CEO & Director | Buy | P | 3.72 | 5,000 | 18,600 | 102,151 | 97.2 K to 102.2 K (+5.15 %) |
| May 29 2018 | NBRV | Nabriva Therapeuti ... | Lavino Francesco Maria | Chief Commercial Of ... | Buy | P | 4.60 | 2,160 | 9,936 | 3,719 | 1.6 K to 3.7 K (+138.55 %) |
| May 29 2018 | NBRV | Nabriva Therapeuti ... | Lavino Francesco Maria | Chief Commercial Of ... | Buy | P | 4.60 | 2,160 | 9,936 | 3,719 | 1.6 K to 3.7 K (+138.55 %) |
| May 23 2018 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Buy | P | 4.57 | 2,000 | 9,140 | 6,200 | 4.2 K to 6.2 K (+47.62 %) |
| May 23 2018 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Buy | P | 4.59 | 8,000 | 36,720 | 8,000 | 0 to 8 K |
| May 23 2018 | NBRV | Nabriva Therapeuti ... | Broom Colin MD | CEO & Director | Buy | P | 4.60 | 10,000 | 46,000 | 97,151 | 87.2 K to 97.2 K (+11.47 %) |
| May 23 2018 | NBRV | Nabriva Therapeuti ... | Crotty Robert | General Counsel & S ... | Buy | P | 4.48 | 10,000 | 44,800 | 10,000 | 0 to 10 K |
| May 04 2018 | NBRV | Nabriva Therapeuti ... | Bourdow Carrie L. | Director | Option Exercise | A | 0.00 | 29,000 | 0 | 29,000 | |
| May 04 2018 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 29,000 | 0 | 29,000 | |
| May 04 2018 | NBRV | Nabriva Therapeuti ... | BURGESS DANIEL D | Director | Option Exercise | A | 0.00 | 29,000 | 0 | 29,000 | |
| May 04 2018 | NBRV | Nabriva Therapeuti ... | CORRIGAN MARK | Director | Option Exercise | A | 0.00 | 29,000 | 0 | 29,000 | |
| May 04 2018 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Option Exercise | A | 0.00 | 29,000 | 0 | 29,000 | |
| May 04 2018 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | A | 0.00 | 29,000 | 0 | 29,000 | |
| Apr 03 2018 | NBRV | Nabriva Therapeuti ... | Schranz Jennifer | Chief Medical Offic ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 22,500 | 0 | 22,500 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 22,500 | 0 | 22,500 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Lavino Francesco Maria | Chief Commercial Of ... | Option Exercise | A | 0.00 | 22,500 | 0 | 22,500 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Lavino Francesco Maria | Chief Commercial Of ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Broom Colin MD | Chief Executive Off ... | Option Exercise | A | 0.00 | 67,500 | 0 | 67,500 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Broom Colin MD | Chief Executive Off ... | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Crotty Robert | Gen Counsel & Corp ... | Option Exercise | A | 0.00 | 22,500 | 0 | 22,500 | |
| Feb 02 2018 | NBRV | Nabriva Therapeuti ... | Crotty Robert | Gen Counsel & Corp ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Dec 01 2017 | NBRV | Nabriva Therapeuti ... | Lavino Francesco Maria | Chief Commercial Of ... | Buy | P | 6.29 | 1,569 | 9,869 | 1,569 | 0 to 1.6 K |
| Sep 29 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Option Exercise | M | 0.00 | 1,350 | 0 | 0 | |
| Sep 29 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Buy | M | 0.00 | 1,350 | 0 | 33,140 | 31.8 K to 33.1 K (+4.25 %) |
| Sep 26 2017 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Buy | P | 8.21 | 2,000 | 16,420 | 4,200 | 2.2 K to 4.2 K (+90.91 %) |
| Sep 26 2017 | NBRV | Nabriva Therapeuti ... | Broom Colin MD | Chief Executive Off ... | Buy | P | 8.35 | 2,588 | 21,610 | 87,151 | 84.6 K to 87.2 K (+3.06 %) |
| Sep 19 2017 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 10,100 | 0 | 10,100 | |
| Sep 19 2017 | NBRV | Nabriva Therapeuti ... | Bourdow Carrie L. | Director | Option Exercise | A | 0.00 | 10,100 | 0 | 10,100 | |
| Sep 19 2017 | NBRV | Nabriva Therapeuti ... | BURGESS DANIEL D | Director | Option Exercise | A | 0.00 | 10,100 | 0 | 10,100 | |
| Sep 19 2017 | NBRV | Nabriva Therapeuti ... | CORRIGAN MARK | Director | Option Exercise | A | 0.00 | 10,100 | 0 | 10,100 | |
| Sep 19 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Option Exercise | A | 0.00 | 10,100 | 0 | 10,100 | |
| Sep 19 2017 | NBRV | Nabriva Therapeuti ... | Webster Stephen W | Director | Option Exercise | A | 0.00 | 10,100 | 0 | 10,100 | |
| Sep 18 2017 | NBRV | Nabriva Therapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 9.46 | 6,386 | 60,412 | 494,329 | 487.9 K to 494.3 K (+1.31 %) |
| Sep 18 2017 | NBRV | Nabriva Therapeuti ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 9.46 | 46,245 | 437,478 | 3,579,861 | 3.5 M to 3.6 M (+1.31 %) |
| Sep 14 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 8.52 | 3,429 | 29,224 | 2,334,128 | 2.3 M to 2.3 M (-0.15 %) |
| Sep 14 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 8.54 | 22,721 | 193,956 | 2,337,557 | 2.4 M to 2.3 M (-0.96 %) |
| Sep 14 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 8.63 | 10,458 | 90,236 | 2,360,278 | 2.4 M to 2.4 M (-0.44 %) |
| Sep 05 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 9.50 | 639 | 6,071 | 2,370,735 | 2.4 M to 2.4 M (-0.03 %) |
| Aug 09 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 2,013 | 21,137 | 2,371,374 | 2.4 M to 2.4 M (-0.08 %) |
| Aug 09 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 17,790 | 186,795 | 2,373,387 | 2.4 M to 2.4 M (-0.74 %) |
| Aug 02 2017 | NBRV | Nabriva Therapeuti ... | Bourdow Carrie L. | Director | Option Exercise | A | 0.00 | 20,200 | 0 | 20,200 | |
| Aug 02 2017 | NBRV | Nabriva Therapeuti ... | Lavino Francesco Maria | Chief Commercial Of ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Aug 01 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.51 | 6,585 | 69,195 | 2,391,177 | 2.4 M to 2.4 M (-0.27 %) |
| Jul 26 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 160 | 1,680 | 2,397,762 | 2.4 M to 2.4 M (-0.01 %) |
| Jul 24 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 23,445 | 246,173 | 2,397,922 | 2.4 M to 2.4 M (-0.97 %) |
| Jul 24 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 20,786 | 218,253 | 2,421,367 | 2.4 M to 2.4 M (-0.85 %) |
| Jul 05 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.95 | 11,352 | 124,250 | 2,571,877 | 2.6 M to 2.6 M (-0.44 %) |
| Jul 05 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.94 | 1,775 | 19,420 | 2,583,229 | 2.6 M to 2.6 M (-0.07 %) |
| Jun 29 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.72 | 1,603 | 17,189 | 2,585,004 | 2.6 M to 2.6 M (-0.06 %) |
| Jun 29 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.10 | 4,789 | 53,158 | 2,586,697 | 2.6 M to 2.6 M (-0.18 %) |
| Jun 29 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.83 | 2,166 | 23,457 | 2,591,396 | 2.6 M to 2.6 M (-0.08 %) |
| Jun 19 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 91.00 | 46 | 4,186 | 3,179 | 3.2 K to 3.2 K (-1.43 %) |
| Jun 19 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 93.50 | 24 | 2,244 | 3,225 | 3.2 K to 3.2 K (-0.74 %) |
| Jun 19 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 94.10 | 100 | 9,410 | 3,249 | 3.3 K to 3.2 K (-2.99 %) |
| Jun 05 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.27 | 400 | 4,508 | 2,593,562 | 2.6 M to 2.6 M (-0.02 %) |
| Jun 01 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 101.00 | 100 | 10,100 | 3,349 | 3.4 K to 3.3 K (-2.90 %) |
| Jun 01 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 101.50 | 110 | 11,165 | 3,449 | 3.6 K to 3.4 K (-3.09 %) |
| May 25 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 101.00 | 90 | 9,090 | 3,559 | 3.6 K to 3.6 K (-2.47 %) |
| May 25 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 100.50 | 205 | 20,603 | 3,649 | 3.9 K to 3.6 K (-5.32 %) |
| May 25 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 99.70 | 30 | 2,991 | 3,854 | 3.9 K to 3.9 K (-0.77 %) |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Option Exercise | M | 0.00 | 578 | 0 | 135 | |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Option Exercise | M | 0.00 | 155 | 0 | 0 | |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Option Exercise | M | 0.00 | 502 | 0 | 0 | |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 103.00 | 100 | 10,300 | 3,884 | 4 K to 3.9 K (-2.51 %) |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 102.27 | 50 | 5,113 | 3,984 | 4 K to 4 K (-1.24 %) |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Sell | S | 101.50 | 50 | 5,075 | 4,034 | 4.1 K to 4 K (-1.22 %) |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Buy | M | 0.00 | 578 | 0 | 4,084 | 3.5 K to 4.1 K (+16.49 %) |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Buy | M | 0.00 | 155 | 0 | 3,506 | 3.4 K to 3.5 K (+4.63 %) |
| May 17 2017 | NBRV | Nabriva Therapeuti ... | Talbot George Harrison | Director | Buy | M | 0.00 | 502 | 0 | 3,351 | 2.8 K to 3.4 K (+17.62 %) |
| Apr 28 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.03 | 15,130 | 166,813 | 2,593,962 | 2.6 M to 2.6 M (-0.58 %) |
| Apr 28 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.00 | 100 | 1,100 | 2,609,092 | 2.6 M to 2.6 M (0.00 %) |
| Apr 28 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.00 | 709 | 7,799 | 2,609,192 | 2.6 M to 2.6 M (-0.03 %) |
| Apr 25 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.04 | 2,622 | 28,937 | 2,609,901 | 2.6 M to 2.6 M (-0.10 %) |
| Apr 20 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.00 | 325 | 3,575 | 2,612,523 | 2.6 M to 2.6 M (-0.01 %) |
| Apr 20 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.07 | 11,785 | 130,434 | 2,612,848 | 2.6 M to 2.6 M (-0.45 %) |
| Apr 20 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.16 | 11,822 | 131,880 | 2,624,633 | 2.6 M to 2.6 M (-0.45 %) |
| Apr 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.13 | 10,984 | 122,232 | 2,636,455 | 2.6 M to 2.6 M (-0.41 %) |
| Apr 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.22 | 13,250 | 148,653 | 2,647,439 | 2.7 M to 2.6 M (-0.50 %) |
| Apr 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.40 | 8,597 | 98,034 | 2,660,689 | 2.7 M to 2.7 M (-0.32 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.73 | 37,876 | 406,451 | 185,394 | 223.3 K to 185.4 K (-16.96 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.96 | 18,001 | 197,291 | 223,270 | 241.3 K to 223.3 K (-7.46 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.04 | 3,500 | 38,640 | 241,271 | 244.8 K to 241.3 K (-1.43 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.20 | 24,600 | 275,520 | 244,771 | 269.4 K to 244.8 K (-9.13 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.28 | 6,617 | 74,640 | 269,371 | 276 K to 269.4 K (-2.40 %) |
| Feb 09 2017 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Option Exercise | A | 0.00 | 11,300 | 0 | 11,300 | |
| Feb 09 2017 | NBRV | Nabriva Therapeuti ... | Seltzer Elyse G. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 11,300 | 0 | 11,300 | |
| Feb 09 2017 | NBRV | Nabriva Therapeuti ... | Gelone Steven P. | Chief Development O ... | Option Exercise | A | 0.00 | 11,300 | 0 | 11,300 | |
| Feb 09 2017 | NBRV | Nabriva Therapeuti ... | Broom Colin MD | Chief Executive Off ... | Option Exercise | A | 0.00 | 26,100 | 0 | 26,100 |